Senores Pharmaceuticals is Listed at a 53% Premium on NSE at โน600 & on BSE at โน593.7
Senores Pharmaceuticals’ shares debuted with a strong 53% premium, listing at โน600 on the NSE and โน593.70 on the BSE. The subscription status and Grey Market premium had pointed to strong listing gains following its public issue, which opened on December 20, 2024, and closed on December 24, 2024. Senores Pharmaceuticals IPO Subscription Status Open … Read more